0001209191-16-153442.txt : 20161205
0001209191-16-153442.hdr.sgml : 20161205
20161205172607
ACCESSION NUMBER: 0001209191-16-153442
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20161201
FILED AS OF DATE: 20161205
DATE AS OF CHANGE: 20161205
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ANTARES PHARMA, INC.
CENTRAL INDEX KEY: 0001016169
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 411350192
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1208
BUSINESS ADDRESS:
STREET 1: 100 PRINCETON SOUTH
STREET 2: SUITE 300
CITY: EWING
STATE: NJ
ZIP: 08628
BUSINESS PHONE: 609-359-3020
MAIL ADDRESS:
STREET 1: 100 PRINCETON SOUTH
STREET 2: SUITE 300
CITY: EWING
STATE: NJ
ZIP: 08628
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC
DATE OF NAME CHANGE: 20060120
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC
DATE OF NAME CHANGE: 20020520
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC /MN/
DATE OF NAME CHANGE: 20010604
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JACOB LEONARD S
CENTRAL INDEX KEY: 0001049713
STATE OF INCORPORATION: NY
FISCAL YEAR END: 0630
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32302
FILM NUMBER: 162034587
MAIL ADDRESS:
STREET 1: C/O INKINE PHARMACEUTICAL COMPANY INC
STREET 2: 425 PARK AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-12-01
0
0001016169
ANTARES PHARMA, INC.
ATRS
0001049713
JACOB LEONARD S
C/O ANTARES PHARMA, INC.
100 PRINCETON SOUTH, SUITE 300
EWING
NJ
08628
1
0
0
0
Common Stock
2016-12-01
4
M
0
20000
1.23
A
238885
D
Common Stock
2016-12-01
4
S
0
20000
1.9708
D
218885
D
Stock Option (right to buy)
1.23
2016-12-01
4
M
0
20000
0.00
D
2017-01-16
Common Stock
20000
0
D
The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
The options vested and became exercisable one year following the grant date, which was January 16, 2007.
/s/ Keith Muckenhirn as attorney-in-fact for Leonard S. Jacob
2016-12-05
EX-24.4_687536
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that I, Dr. Leonard S. Jacob, hereby
constitute and appoint James E. Fickenscher, Peter J. Graham and Keith
Muckenhirn, each of them, my true and lawful attorneys-in-fact and agents, each
acting alone, with full powers of substitution and resubstitution for me and in
my name, place and stead, to sign any reports on Form 3 (Initial Statement of
Beneficial Ownership), Form 4 (Statement of Changes in Beneficial Ownership of
Securities) and Form 5 (Annual Statement of Changes in Beneficial Ownership)
relating to transactions by me in Common Stock or other securities of Antares
Pharma, Inc., and all amendments thereto, and to file the same with the
Securities and Exchange Commission and appropriate securities listing agency, if
required, granting unto said attorneys-in-fact and agents, and each of them, or
their substitutes, full power and authority to do and perform each and every act
and thing requisite or necessary to be done, as fully to all intents and
purposes as I might or could do in person, hereby ratifying and confirming all
that said attorneys-in-fact and agents, and each of them, or their substitutes,
may lawfully do or cause to be done by virtue hereof. This Power of Attorney
shall be effective until such time as I deliver a written revocation thereof to
my above-named attorneys-in-fact and agents.
/s/ Leonard S. Jacob
Dated: June 2, 2016